The Monoclonal Antibody Therapy Market is expected to reach USD 230.38 Bn by 2031 and was valued at USD 87.8 Bn in 2023 and will grow at a CAGR of 12.8% over the forecast period of 2024-2031.The Monoclonal Antibody Therapy Market is experiencing significant growth, driven by advancements in biotechnology and a rising prevalence of chronic diseases such as cancer, rheumatoid arthritis, and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian